Amylyx Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- FedEx pilots ratify new collective bargaining agreement
- The real reason Meta shares are surging has nothing to do with its new AI model
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Amylyx Pharmaceuticals (AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
March 30, 2022 4:51 PM EDT(Updated - March 30, 2022 4:51 PM EDT)
Amylyx Pharmaceuticals (NASDAQ: AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
... MoreAmylyx Pharmaceuticals (AMLX) Confirms Shares Halted Ahead of FDA Advisory Committee Meeting to Discuss NDA for AMX0035 for the Treatment of ALS
March 30, 2022 7:07 AM EDTAmylyx Pharmaceuticals (NASDAQ: AMLX) today announced that Nasdaq has halted trading of the companys common stock.
The U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) is meeting today to review the New Drug Application... More
